Sphera Funds Management Ltd. Erytech Pharma S.A. Transaction History

Sphera Funds Management Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$4.02 - $7.38 $473,704 - $869,637	-117,837 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$4.23 - $7.0 $5,076 - $8,400	-1,200 Reduced 1.01%	117,837 $523,000
Q2 2019 Aug 14, 2019	SELL	$6.37 - $8.24 $6,134 - $7,935	-963 Reduced 0.8%	119,037 $0
Q3 2018 Nov 14, 2018	BUY	$8.57 - $11.41 $1.03 Million - $1.37 Million	120,000 New	120,000 $1.05 Million
Q2 2018 Aug 13, 2018	SELL	$11.17 - $21.41 $1.34 Million - $2.57 Million	-120,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$17.93 - $30.3 $2.15 Million - $3.64 Million	120,000	120,000 $2.64 Million

Ticker ERYP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,018,600
Market Cap $16.8M
Description
ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.